Label Changes for:
Noroxin (norfloxacin) Tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
- muscle spasms
- DRESS (drug rash with eosinophilia and systemic symptoms) syndrome